During the recent session, Tenaya Therapeutics Inc (NASDAQ:TNYA)’s traded shares were 0.66 million, with the beta value of the company hitting 2.84. At the last check today, the stock’s price was $1.07, reflecting an intraday gain of 12.98% or $0.12. The 52-week high for the TNYA share is $7.01, that puts it down -555.14 from that peak though still a striking 19.63% gain since the share price plummeted to a 52-week low of $0.86. The company’s market capitalization is $84.77M, and the average intraday trading volume over the past 10 days was 1.81 million shares, and the average trade volume was 4.21 million shares over the past three months.
Tenaya Therapeutics Inc (TNYA) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. TNYA has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.31.
Tenaya Therapeutics Inc (NASDAQ:TNYA) trade information
Tenaya Therapeutics Inc (TNYA) registered a 12.98% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 12.98% in intraday trading to $1.07, hitting a weekly high. The stock’s 5-day price performance is 10.94%, and it has moved by -27.21% in 30 days. Based on these gigs, the overall price performance for the year is -79.62%. The short interest in Tenaya Therapeutics Inc (NASDAQ:TNYA) is 12.24 million shares and it means that shorts have 6.03 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -27.43%. While earnings are projected to return 19.60% in 2025, the next five years will return 8.78% per annum.
TNYA Dividends
Tenaya Therapeutics Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Tenaya Therapeutics Inc (NASDAQ:TNYA)’s Major holders
Tenaya Therapeutics Inc insiders own 1.57% of total outstanding shares while institutional holders control 78.79%, with the float percentage being 80.05%. COLUMN GROUP LLC is the largest shareholder of the company, while 130.0 institutions own stock in it. As of 2024-06-30, the company held over 9.4 million shares (or 11.6078% of all shares), a total value of $29.14 million in shares.
The next largest institutional holding, with 7.62 million shares, is of RA CAPITAL MANAGEMENT, L.P.’s that is approximately 9.4124% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $23.63 million.
Also, the Mutual Funds coming in first place with the largest holdings of Tenaya Therapeutics Inc (TNYA) shares are Price (T.Rowe) New Horizons Fund and Vanguard Total Stock Market Index Fund. Data provided on Sep 30, 2024 indicates that Price (T.Rowe) New Horizons Fund owns about 2.1 shares. This amounts to just over 2.65 percent of the company’s overall shares, with a $2.27 million market value. The same data shows that the other fund manager holds slightly less at 2.06, or about 2.61% of the stock, which is worth about $2.23 million.
